The primary antibodies employed were: P53 (Proteintech, 60283-2-Ig), pSer46-P53 (CST, 2521), FOXO4 (Proteintech, 21535-1-AP), P21 (CST, 2947), P16 (CST, 18769), BAX (CST, 2772), BCL2 (CST, 3498), Ki-67 (Proteintech, 84192-4-RR), Lamin B (CST, 13435), Cleaved Caspase 3 (CST, 9664), -H2AX (Abcam, ab81299), and GAPDH (Abcam, ab8245) as an internal reference for normalizing protein expression levels
No medical claims are made, expressed, or implied
They are rich enough to afford expensive treatment
Research-grade BPC-157 + TB-500 is commonly utilized for peptide characterization, analytical chemistry, laboratory method development, stability studies, and other experimental investigations described in scientific literature
Risk 5: Loss of Appetite Regulation Poor absorption = unstable appetite control and inconsistent metabolic response